MiniMed 780G in Kuwait to assist diabetes sufferers


KUWAIT: Under the auspices of the Department of Health and the Kuwait Diabetes Society, Medtronic, the world’s leading provider of medical technology, announced the launch of the MiniMed 780G system in Kuwait. This advanced next-generation AHCL (Hybrid Closed Loop) insulin pump system anticipates the patient’s insulin needs and adjusts insulin delivery itself. At the same time, it uses smartphone connectivity to facilitate access to information.

Dr. Abdullah Al-Badr, Deputy Undersecretary of State at the Ministry of Health, said: “Diabetes is a pressing problem right now, which the current pandemic has further highlighted as people with diabetes are more likely to have serious complications from COVID-19.” He continued, “It is therefore important that we continue to raise awareness of the importance of disease management and explore ways in which we can use technology to improve the lives of patients. The health and safety of people with diabetes is one of our priorities. We are therefore grateful for the efforts of the health sector in Jassim Al-Wazzan Sons and Medtronic to ensure this. “

“The introduction of the MiniMed 780G is the latest example of how Medtronic uses intelligent algorithms to improve patient outcomes and simplify decision-making for people with diabetes, leveraging the company’s extensive data science and AI capabilities,” said Majid Kaddoumi, President of Medtronic Central and Eastern Europe, Middle East and Africa. “From the intelligent pump to the intelligent pen, our portfolio offers innovative technology-based solutions for people in different phases of their diabetes therapy.”

Dr. Rashed Khazal, general manager of the health sector at Jassim Al-Wazzan Sons General Trading Co, the distributor of Medtronic products in Kuwait and one of the subsidiaries of the Mezzan Holding Company, said, “The pandemic is exacerbating the need for new and smarter products. We stopped it to partner with Medtronic to bring the MiniMed 780G to market so that people with type 1 diabetes can focus more on their lives and less on diabetes. We are already seeing the effects of this and have had positive feedback from doctors around the world who have noted the simplicity of the pump which has allowed patients to adjust to this system very quickly, giving them the freedom and control to improve their quality of life. “

Dr. Waleed Al-Dahi; The Consultative Endocrinologist and President of the Kuwait Diabetes Society said, “Research has shown that the incidence of type 1 diabetes in Kuwait has doubled over the past 20 years, highlighting the urgent need to address the burden of the disease. Medical technology is now considered the center for the treatment of diabetes. With the new technological breakthrough, diabetics can better manage their diabetes and lead better lives. Medtronic has always provided cutting-edge technology to help better manage diabetes. “

Despite advances in technology and the increasing use of continuous glucose monitoring (CGM), many people with diabetes, especially teenagers, have problems with blood sugar control and the daily challenges of managing their condition. Approved for use in people ages 7 to 80, the MiniMed 780G system anticipates insulin needs and uses the company’s most advanced SmartGuard algorithm to stop basal insulin and correction boluses being delivered every five hours as needed, 24/7 Minutes to automate. Helping more people with diabetes avoid ups and downs more easily and achieve their glycemic goals with less effort.

The MiniMed 780G system has a Bluetooth connection that allows users to easily track pump and CGM information with custom options for alerts and real-time glucose trends. In addition, thanks to the CareLink Connect app, information is automatically and securely shared with caregivers and healthcare professionals.